Jacobson Pharma Corporation Limited (HKG:2633)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.180
+0.020 (1.72%)
Mar 21, 2025, 4:08 PM HKT

Jacobson Pharma Corporation Company Description

Jacobson Pharma Corporation Limited, through its subsidiaries, develops, produces, markets, and sells generic drugs and branded healthcare products in Hong Kong, Mainland China, Macau, Singapore, and internationally.

The company offers generic drugs for various therapeutic categories, including gastrointestinal disorders, cardiovascular conditions, inflammatory and autoimmune diseases, multiple myeloma treatment, oncology, breast cancer therapy, central nervous system, respiratory, oral antidiabetics, musculo-skeletal, genito-urinary, anti-infectives, endocrine and metabolic, dermatological, and anti-allergics.

It also provides branded medicines; health and wellness products; and proprietary Chinese medicines; treasury services; and management services.

In addition, the company engages in the manufacture, sale, trading of pharmaceutical products; property holding activities; holding of pharmaceutical licenses; trading of medical supplies; sales of healthcare and herbal products; and procurement of packaging materials.

It sells its products to hospitals and clinics, and registered pharmacies, as well as to private doctors and retail outlets, and trading companies.

Jacobson Pharma Corporation Limited was incorporated in 2016 and is headquartered in Kwun Tong, Hong Kong.

Jacobson Pharma Corporation Limited
Country Cayman Islands
Founded 2016
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 1,723
CEO Kwong Yip Sum

Contact Details

Address:
Tower 1, Millennium City 1
Kwun Tong
Hong Kong
Phone 852 2267 2298
Website jacobsonpharma.com

Stock Details

Ticker Symbol 2633
Exchange Hong Kong Stock Exchange
Fiscal Year April - March
Reporting Currency HKD
ISIN Number KYG677291067
SIC Code 2834

Key Executives

Name Position
Kwong Yip Sum Chairman, Chief Executive Officer and Member of Scientific Advisory Committee
Yue Wai Pun Vice President of Administration and Executive Director
Chun Leung Yim ACA, CPA, FCCA, MBA Executive Director
Chun Kau Yu ACS, FCPA Chief Financial Officer and Company Secretary
Yu Sun Wong Executive Vice President of Operation Management
Kin Man Chan Vice President of Sales
Chi Shing Cheng Vice President of Human Resources